Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer

NCT07531329 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT07531329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07531329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 5, 2021
Completion date
March 5, 2028
Enrollment
1,000 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

molecular imaging, suspected prostate cancer, treatment-naive prostate cancer